These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15579006)

  • 1. ET-18-OCH3 (edelfosine): a selective antitumour lipid targeting apoptosis through intracellular activation of Fas/CD95 death receptor.
    Mollinedo F; Gajate C; Martín-Santamaría S; Gago F
    Curr Med Chem; 2004 Dec; 11(24):3163-84. PubMed ID: 15579006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of apoptosis in human mitogen-activated peripheral blood T-lymphocytes by the ether phospholipid ET-18-OCH3: involvement of the Fas receptor/ligand system.
    Cabaner C; Gajate C; Macho A; Muñoz E; Modolell M; Mollinedo F
    Br J Pharmacol; 1999 Jun; 127(4):813-25. PubMed ID: 10433487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activities, mechanisms of action and biomedical prospect of the antitumor ether phospholipid ET-18-OCH(3) (edelfosine), a proapoptotic agent in tumor cells.
    Gajate C; Mollinedo F
    Curr Drug Metab; 2002 Oct; 3(5):491-525. PubMed ID: 12369895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of raft aggregates enriched in Fas/CD95 death-inducing signaling complex in the antileukemic action of edelfosine in Jurkat cells.
    Gajate C; Gonzalez-Camacho F; Mollinedo F
    PLoS One; 2009; 4(4):e5044. PubMed ID: 19352436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular triggering of Fas, independently of FasL, as a new mechanism of antitumor ether lipid-induced apoptosis.
    Gajate C; Fonteriz RI; Cabaner C; Alvarez-Noves G; Alvarez-Rodriguez Y; Modolell M; Mollinedo F
    Int J Cancer; 2000 Mar; 85(5):674-82. PubMed ID: 10699948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L).
    Mollinedo F; Fernández-Luna JL; Gajate C; Martín-Martín B; Benito A; Martínez-Dalmau R; Modolell M
    Cancer Res; 1997 Apr; 57(7):1320-8. PubMed ID: 9102220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular triggering of Fas aggregation and recruitment of apoptotic molecules into Fas-enriched rafts in selective tumor cell apoptosis.
    Gajate C; Del Canto-Jañez E; Acuña AU; Amat-Guerri F; Geijo E; Santos-Beneit AM; Veldman RJ; Mollinedo F
    J Exp Med; 2004 Aug; 200(3):353-65. PubMed ID: 15289504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts.
    Gajate C; Mollinedo F
    Blood; 2007 Jan; 109(2):711-9. PubMed ID: 17003375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and In vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts.
    Mollinedo F; de la Iglesia-Vicente J; Gajate C; Estella-Hermoso de Mendoza A; Villa-Pulgarin JA; de Frias M; Roué G; Gil J; Colomer D; Campanero MA; Blanco-Prieto MJ
    Clin Cancer Res; 2010 Apr; 16(7):2046-54. PubMed ID: 20233887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of c-Jun NH2-terminal kinase activation and c-Jun in the induction of apoptosis by the ether phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
    Gajate C; Santos-Beneit A; Modolell M; Mollinedo F
    Mol Pharmacol; 1998 Apr; 53(4):602-12. PubMed ID: 9547349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of the effect of the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-glycero-3-phosphocholine and some homologous compounds on PKC alpha and PKC epsilon.
    Conesa-Zamora P; Mollinedo F; Corbalán-García S; Gómez-Fernández JC
    Biochim Biophys Acta; 2005 Feb; 1687(1-3):110-9. PubMed ID: 15708359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fas/CD95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy.
    Mollinedo F; Gajate C
    Drug Resist Updat; 2006; 9(1-2):51-73. PubMed ID: 16687251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antitumor ether lipid ET-18-OCH(3) induces apoptosis through translocation and capping of Fas/CD95 into membrane rafts in human leukemic cells.
    Gajate C; Mollinedo F
    Blood; 2001 Dec; 98(13):3860-3. PubMed ID: 11739199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
    Chabot MC; Wykle RL; Modest EJ; Daniel LW
    Cancer Res; 1989 Aug; 49(16):4441-5. PubMed ID: 2743333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of antitumor ether lipid with lipids of complementary molecular shape reduces its hemolytic activity.
    Perkins WR; Dause RB; Li X; Franklin JC; Cabral-Lilly DJ; Zha Y; Dank EH; Mayhew E; Janoff AS
    Biochim Biophys Acta; 1997 Jul; 1327(1):61-8. PubMed ID: 9247167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation of the effects of the antitumour ether lipid ET-18-OCH3 on cytosolic calcium and on apoptosis.
    Alonso MT; Gajate C; Mollinedo F; Modolell M; Alvarez J; García-Sancho J
    Br J Pharmacol; 1997 Aug; 121(7):1364-8. PubMed ID: 9257915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alkyl ether lipids, ion channels and lipid raft reorganization in cancer therapy.
    Jaffrès PA; Gajate C; Bouchet AM; Couthon-Gourvès H; Chantôme A; Potier-Cartereau M; Besson P; Bougnoux P; Mollinedo F; Vandier C
    Pharmacol Ther; 2016 Sep; 165():114-31. PubMed ID: 27288726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The degradation of platelet-activating factor and related lipids: susceptibility to phospholipases C and D.
    Wilcox RW; Wykle RL; Schmitt JD; Daniel LW
    Lipids; 1987 Nov; 22(11):800-7. PubMed ID: 3444369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidylcholine attenuates the cytotoxic effects of the antineoplastic phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3- phosphocholine.
    Boggs KP; Rock CO; Jackowski S
    J Biol Chem; 1995 May; 270(19):11612-8. PubMed ID: 7744800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis triggered by 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine is prevented by increased expression of CTP:phosphocholine cytidylyltransferase.
    Baburina I; Jackowski S
    J Biol Chem; 1998 Jan; 273(4):2169-73. PubMed ID: 9442058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.